Relay Therapeutics
Relay Therapeutics, based in Cambridge, MA, specializes in precision oncology and genetic diseases using its Dynamo platform for advanced drug discovery.
Headquarters of Relay Therapeutics
Relay Therapeutics is headquartered in Cambridge, MA. This strategic location situates the company within a prominent hub for biotechnology and pharmaceutical innovation, allowing it to leverage local resources and talent in its drug discovery efforts.
Relay Therapeutics' Dynamo Platform
Relay Therapeutics utilizes the Dynamo platform for drug discovery. This platform integrates advanced computational and experimental technologies to develop novel drug candidates. By leveraging these technologies, Relay aims to address targets that have been previously considered intractable or inadequately drugged.
Focus Areas of Relay Therapeutics
Relay Therapeutics focuses on precision oncology and genetic diseases. The company's approach emphasizes developing therapies that specifically target the unique genetic drivers of these diseases, aiming to improve patient outcomes by addressing the underlying causes with precision treatments.
Relay Therapeutics Product Pipeline
Relay Therapeutics is developing a pipeline of therapeutic candidates, including RLY-4008 and RLY-2608. These drug candidates are currently being investigated in clinical trials, with the aim of providing new treatments for various oncological and genetic conditions.
Collaboration with Genentech
Relay Therapeutics has entered into a collaboration agreement with Genentech for the development and commercialization of GDC-1971. This partnership leverages the combined expertise and resources of both companies to advance the development of innovative therapeutic solutions.